Related Articles
Establishment and characterization of the gemcitabine‑resistant human pancreatic cancer cell line SW1990/gemcitabine
STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo
JAK2 inhibitor blocks the inflammation and growth of esophageal squamous cell carcinoma in vitro through the JAK/STAT3 pathway
Emodin potentiates the antitumor effects of gemcitabine in pancreatic cancer cells via inhibition of nuclear factor-κB
Antitumorigenic effect of plumbagin by induction of SH2‑containing protein tyrosine phosphatase 1 in human gastric cancer cells